BAM
TCRR

Belpointe Asset Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Belpointe Asset Management’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,147
Closed -$2.14K – 3896
2022
Q4 		$2.14K Buy
+2,147
New +$2.14K ﹤0.01% 3235